These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 43004)

  • 21. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 22. Aluminum determination in whole blood, dialysis solution, and tap water samples from Maracaibo dialysis units (Venezuela) by graphite furnace atomic absorption spectrometry.
    Navarro JA; Parra OE; Romero RA
    J Trace Elem Electrolytes Health Dis; 1988 Mar; 2(1):3-8. PubMed ID: 2980789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ; Cowie JF; Robson JS
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progressive dialytic encephalopathy. Role of the aluminium and neurological study. One case (author's transl)].
    Buge A; Escourolle R; Poisson M; Gray F; Bleibel JM; Jaudon MC
    Nouv Presse Med; 1979 Mar; 8(13):1071-4. PubMed ID: 461135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemic dialysis encephalopathy.
    Hocken AG
    Clin Nephrol; 1984 Feb; 21(2):140. PubMed ID: 6723114
    [No Abstract]   [Full Text] [Related]  

  • 26. Dialysis encephalopathy.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997
    [No Abstract]   [Full Text] [Related]  

  • 27. Dialysis encephalopathy in Kuala Lumpur.
    Abu Bakar Suleiman ; Rejab SM; Khoo HE
    Med J Malaysia; 1986 Mar; 41(1):12-8. PubMed ID: 3796341
    [No Abstract]   [Full Text] [Related]  

  • 28. [Two forerunners of the encephalopathy of hemodialysed patients : osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)].
    Vecchierini-Blineau MF; Thébaud HE; Brochard D; Coville P
    Nephrologie; 1980; 1(1):29-32. PubMed ID: 7301017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progressive dialytic encephalopathy].
    Rabey JM; Blum M; Vardi J; Aviram A; Moriel EZ; Streifler M
    Harefuah; 1980 Mar; 98(5):205-7. PubMed ID: 7409633
    [No Abstract]   [Full Text] [Related]  

  • 30. [The importance of aluminiun in dialyseencephalopathie (author's transl)].
    Ladurner G; Holzer H; Wawschinek O; Pogglitsch H; Petek W
    Fortschr Neurol Psychiatr; 1981 May; 49(5):211-3. PubMed ID: 7239409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The K/DOQI guidelines on diagnosis and treatment of aluminum bone disease in hemodialysis patients].
    Nakazawa R
    Clin Calcium; 2004 May; 14(5):738-43. PubMed ID: 15577035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technical aspects of quantification of aluminum.
    Chan S; Gerson B
    Clin Lab Med; 1990 Jun; 10(2):423-33. PubMed ID: 2197056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The presence of trace quantities of aluminum in dialysates as a risk factor in peritoneal dialysis].
    Gilli P; Fagioli F; De Bastiani P; Boldrini P; Malacarne C; Rosati G
    Boll Soc Ital Biol Sper; 1981 Mar; 57(6):659-65. PubMed ID: 7272037
    [No Abstract]   [Full Text] [Related]  

  • 34. Aluminum and iron overload in chronic dialysis.
    Ackrill P; Day JP; Ahmed R
    Kidney Int Suppl; 1988 Mar; 24():S163-7. PubMed ID: 3283407
    [No Abstract]   [Full Text] [Related]  

  • 35. [Progressive myoclonic encephalopathy in dialysis patients: presence of high concentrations of aluminium in the lysosomes of the cerebral cells (author's transl)].
    Galle P; Chatel M; Berry JP; Menault F
    Nouv Presse Med; 1979 Dec; 8(50):4091-4. PubMed ID: 530824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma aluminium: a redundant test for patients on dialysis?
    Gault PM; Allen KR; Newton KE
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):51-4. PubMed ID: 15802033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived aluminum-related disease in a dialysis population. A report from the End-Stage Renal Disease Network 28.
    Brem AS; DiMario C; Levy DL
    Arch Intern Med; 1989 Nov; 149(11):2541-4. PubMed ID: 2818112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water treatment and dialysis dementia.
    Lancet; 1982 Nov; 2(8307):1106-7. PubMed ID: 6127571
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dialysis encephalopathy, dialysis dementia].
    Kinugasa E; Ideura T; Akizawa T
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):139-42. PubMed ID: 11031916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.